METTL3 and neoplasm: Mechanistically, catalytic inhibition of METTL3 results in dsRNA formation and potent cell‐intrinsic interferon responses that can stimulate anti‐tumour immunity, which is distinct to the mechanism of the current ICBs and cell therapy.